
ImageneBio, Inc.
ImageneBio, Inc. (IMA)
WebsitePrice
Market cap
Next catalystExpected Q4 2027olevaprubart — ADAPTIVE · Phase 2 dataCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved